Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease

Jos Prickaerts*, Pim R A Heckman, Arjan Blokland

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Investigational phosphodiesterase inhibitors in phase I and phase II clinical trials for Alzheimer's disease'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

INIS